Atropine Sulfate Injection, Solution
Product Images NDC 0409-1630
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Atropine Sulfate (NDC 0409-1630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Hospira Logo (Atropine 02)
Principal Display Panel (10 mL Syringe Label)
This is a description for a single-dose syringe of Atropine Sulfate injection, usp. The syringe contains 1mg/10mL (0.1mg/mL) and is designed for intravenous use. The product is distributed by Hospira, Inc, based in Lake Forest, IL, USA. The lot number is included as "LOT ##-##H-AR" and there is information about the expiration date, but the exact date is not provided.*
Principal Display Panel (10 mL Syringe Carton)
This text contains information about the usage and composition of Atropine Sulfate. The text mentions to use Aseptic Technique and remove luer cover for adminstration. It also indicates that the recommended quantity is 1mg/10 mL and the name of the manufacturing company Hospia, Inc. along with the batch number and expiry date. The text also mentions the drug composition as 1mg/10 mL (0.1 mg/mL).*
Principal Display Panel (0.1 mg/mL Syringe Label)
This is a description of Atropine Sulfate, a medication used for intravenous use in pediatric patients. The dosage strength is 0.25 mg/5 mL (0.05 mg/mL), and it is supplied in a single-dose syringe with an NDC code of 0409-9630-15. The medication is produced by Hospira, Inc in Lake Forest, Illinois, with a lot number and expiration date provided.*
Principal Display Panel (0.1 mg/mL Syringe Carton)
This is a description of a medication called "Pediatric Atropine Injection, USP", with a concentration of 0.25mg/5mL (0.05mg/mL). It comes in a single-dose syringe and is for intravenous use only. The syringe is aseptic and non-pyrogenic. The medication is made in Spain and distributed by Hospira, Inc. in the USA. There are instructions on how to use the syringe, with images indicating how to remove the cover and expel air. The packaging indicates the lot number and expiration date.*
Principal Display Panel (0.05 mg/mL Syringe Label)
This is a description of a single-dose syringe with 0.5mg/5mL concentration of atropine sulfate injection (USP). It is for intravenous use only and requires a prescription. The syringe is distributed by Hospira, Inc. with NDC number 0409-4970-11. The product information also includes an identification number: RL-5314.*
Principal Display Panel (0.05 mg/mL Syringe Carton)
Atropine 09
Atropine 10
This is a set of instructions for using and assembling a vial and injector of Sulfate Injection, USP with a concentration of 1 mg/10 mL (0.1 mg/mL). The text also provides a caution to handle the liquid in the vial carefully and inspect it for damage before assembly. It also provides instructions for accessing the green male luer lock adapter and the needle, and for gently initiating liquid flow without applying excessive force to the vial. The text also includes the lot number (EHHHAA) and expiration date (DMMMYYYY) of the product, as well as the code 0030409491113.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.